SAFETY AND TOLERABILITY OF AN ORAL CONTRACEPTIVE CONTAINING LOW-DOSE ETHINYL ESTRADIOL COMBINED WITH GLECAPREVIR/PIBRENTASVIR TREATMENT IN HEALTHY PREMENOPAUSAL WOMEN: RESULTS OF A PHASE 1 STUDY

Conference Reports for NATAP

AASLD
The Liver Meeting
November Fri, Nov 10, 2023 - Mon, Nov 14, 2023


SAFETY AND TOLERABILITY OF AN ORAL CONTRACEPTIVE CONTAINING LOW-DOSE ETHINYL ESTRADIOL COMBINED WITH GLECAPREVIR/PIBRENTASVIR TREATMENT IN HEALTHY PREMENOPAUSAL WOMEN: RESULTS OF A PHASE 1 STUDY

	AASLD 2023 nov 10-14 https://www.aasld.org/the-liver-meeting